Structure of compound 15a

reversible ATX inhibitor w/ alt. binding mode

in vivo PD observed on oral dosing

from HTS screen and opt.

Bioorg. Med. Chem. Lett., Nov. 4, 2020

Novartis, Horsham, UK / Basel, CH

“compound 15a” (Novartis reversible in vivo ATX inhibitor)


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.